Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
HSBC Midcap Fund Reg (G)
[Equity: Mid Cap]  
 
Fund Details
Fund Type Growth Launch Date 09-Aug-04
Corpus(Cr.) 16800.00 Latest NAV 442.6704 As on 29-10-2026
Equity(%) 99.18 52 Week High 485.329
Debt(%) 0.82 52 Week Low 362.728
Others(%) 0.00 Exit Load For units in excess of 10% of the investment, 1% will be charged for redemption within 365 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark NIFTY Midcap 150 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Cheenu Gupta
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long-term capital growth from an actively managed portfolio of equity and equity related securities of predominantly mid cap companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 21.22%
Top 10 Holdings 36.79%
Top 25 Holdings 69.20%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Banking & Financial 16.12
Electricals 15.44
Retail 14.6
Automobile 8.56
Pharma & Biotech 7.91
Finance & Investments 7.32
Industrial Products 5.44
Software & Services 4.18
Food Beverage & Tobacco 4.14
Healthcare 3.1
Technology 2.92
Energy 2.28
Chemicals 2.01
Transportation 1.77
Aerospace & Defence 1.71
Agricultural & Farm Machinery 1.48
Cash 0.82
Consumer Durables 0.14
Miscellaneous 0.03
Construction 0.02
Telecom 0.01
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.06
PE Ratio 41.87
 
Top 25 Holdings
Holdings Net Asset(%)
Lenskart Solutions Limited 5.08
Meesho Limited 5.04
Federal Bank Ltd. 3.90
Aditya Infotech Limited 3.64
Piramal Finance Limited 3.56
FSN E-Commerce Ventures Limited 3.38
Apar Industries Ltd 3.16
GE Vernova T&D India Limited 3.09
Ather Energy Limited 3.03
Dhoot Transmission Limited 2.91
Radico Khaitan Ltd. 2.89
Zydus Lifesciences Limited 2.82
Bharat Forge Ltd 2.61
AU Small Finance Bank Limited 2.34
HITACHI ENERGY INDIA LIMITED 2.28
COFORGE LIMITED 2.28
Mankind Pharma Limited 2.22
Mahindra & Mahindra Financial Services Limited 2.03
Navin Fluorine International Limited 2.01
NIPPON LIFE INDIA ASSET MANAGEMENT LIMITED 2.01
NETWEB TECHNOLOGIES INDIA LIMITED 1.89
Thyrocare Technologies Limited 1.80
SHADOWFAX TECHNOLOGIES LIMITED 1.77
Ipca Laboratories Ltd. 1.75
Data Patterns (India) Limited 1.71

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-2.08% -2.21% 3.49% 9.73%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [NSE - Nifty Midcap 150 TRI]
-2.74% -7.99% -4.00% -3.65%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
6.71% 20.85% 16.22% 15.18%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
1.51% 14.17% 14.04% 15.82%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
HSBC Midcap Fund Reg (G) 20.66% 0.8451 15.4143% 39.4595 0.1072
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
HSBC Midcap Fund Reg (G) 16.0227% 0.0000 -1.4694 24.1007 1.5806
 
Back to Selection